Stories Tagged as
Science
Big telecom winner: Qwest
by
Alisa Roth
Mar 30, 2007
Qwest, Verizon and AT&T have been granted the right to compete for the federal government's telecom contracts, a decision which propels Qwest into the top-tier providers. The big loser: Sprint.
Losing our technological footing
Mar 29, 2007
The U.S. — which previously led the world in technological innovation — has slipped all the way to No. 7, according rankings put out by the World Economic Forum in Switzerland.
Budget dodges killer asteroids
Mar 28, 2007
Hard choices have to be made as Congress hammers out a new budget, but Robert Reich wonders why lawmakers aren't throwing more cash NASA's way to protect us from planetary destruction — and why other countries aren't pitching in.
Tracking carbon reduction's payoff
by
Sam Eaton
Mar 28, 2007
As more and more U.S. cities and corporations sign agreements to reduce their greenhouse gas emissions, there's one lingering question: Is it working? Federal scientists are developing a new modeling tool to find out.
Unknown risks in the big business of tiny science
Mar 28, 2007
Nanotechnology has already quietly influenced hundreds of consumer products, but now Britain's top scientific advisory body is calling for more research on potential hazards of the fast-growing and profitable industry.
Open source science
by
Janet Babin
Mar 28, 2007
Generally, only successful experiments are published in scientific journals, so researchers spend a lot of time repeating ones that fail. But now one professor and his students are breaking tradition and publishing <i>all</i> their findings online.
Coming soon: Bank by cell phone
Mar 28, 2007
AT&T is working with four major banks so that their customers can check their accounts and pay bills from their cell phones. And there won't even be extra fees — at least initially.
For public good, not for profit.
Dot-comspiracy?
by
Amy Scott
Mar 27, 2007
The Supreme Court takes up a case today that could have big implications on Wall Street. Investment banks are accused of conspiring to inflate IPO prices during the '90s dot-com boom and subsequent bust. And a whole lotta money hangs in the balance.
Biogenerics on the slow road to market
by
Steve Henn
Mar 27, 2007
Biologics are among the most expensive drugs in the world — in part because the government has never cleared a path to allow generic drugmakers to compete. That could soon change, but there are safety roadblocks ahead.
Good outlook for Vista sales
by
Jason Paur
Mar 27, 2007
Turns out early forecasts calling for lackluster sales of Vista may have been off. Microsoft has released the first sales figures for its new operating system and they're not too shabby.